Very few studies across an area of ​​the country such as ours, said Whetten. The design flaw of previous studies that compared a small number of orphanages on the homes of the community. These limited results can not be generalized to other places.

Read More

The Company recently announced July 23, 2010 Filing of 510 with the FDA for the ALRT system HEC. The system will be available for sale in the United States pending 510 expected before the end of 2010.

Read More

Rules for a new era genomics

Posted in Healthcare by admin - Mar 02 2012

Recent years have seen major advances in genetic sequencing technology, for which we have seen an explosion in the amount of publicly available data, said the chain, which is the principal author of the journal Science. The amount of base pairs of sequence data is generated every day in billions -. orders of magnitude larger than what has been generated for several years sequencing technologies have different levels of accuracy of uncertainty in a sequence can lead researcher on a wrong path that could take a year or more. Now we need standards that allow researchers to estimate unequivocally the quality of genetic sequence data

Read More

‘The vaccines against these parasitic diseases are a major challenge for public health and the economy, particularly in the veterinary field,’ said CEO Andre Choulika Cellectis. ‘We are delighted to work with VitamFero in this field to promote the development of a new application of our technology.’

Read More

Patients aged 15 to 17 years with children now have access to a cost-effective treatment for this debilitating disease, under the direction of the new NICE neighbor. NICE has today published a final determination assessment , which recommends the use of aripiprazole as an option for the treatment of schizophrenia in people between 15 and 17 years who are intolerant of risperidone or risperidone is contra-indicated, or whose schizophrenia has not been adequately controlled with risperidone.

Read More